FR2601876B1 - Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique - Google Patents

Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique

Info

Publication number
FR2601876B1
FR2601876B1 FR878710368A FR8710368A FR2601876B1 FR 2601876 B1 FR2601876 B1 FR 2601876B1 FR 878710368 A FR878710368 A FR 878710368A FR 8710368 A FR8710368 A FR 8710368A FR 2601876 B1 FR2601876 B1 FR 2601876B1
Authority
FR
France
Prior art keywords
cysteine
acetyl
water
pharmaceutical composition
citric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR878710368A
Other languages
English (en)
Other versions
FR2601876A1 (fr
Inventor
Annibale Gazzaniga
Valter Gianesello
Federico Stroppolo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inpharzam International SA
Original Assignee
Inpharzam International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharzam International SA filed Critical Inpharzam International SA
Publication of FR2601876A1 publication Critical patent/FR2601876A1/fr
Application granted granted Critical
Publication of FR2601876B1 publication Critical patent/FR2601876B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR878710368A 1986-07-24 1987-07-22 Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique Expired FR2601876B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2975/86A CH667590A5 (it) 1986-07-24 1986-07-24 Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .

Publications (2)

Publication Number Publication Date
FR2601876A1 FR2601876A1 (fr) 1988-01-29
FR2601876B1 true FR2601876B1 (fr) 1989-10-13

Family

ID=4245841

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878710368A Expired FR2601876B1 (fr) 1986-07-24 1987-07-22 Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique

Country Status (8)

Country Link
BE (1) BE1000355A3 (fr)
CH (1) CH667590A5 (fr)
DE (1) DE3723735A1 (fr)
FR (1) FR2601876B1 (fr)
GB (1) GB2192790B (fr)
IT (1) IT1222104B (fr)
NL (1) NL194067C (fr)
SE (1) SE500494C2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
DE3822096A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Stabilisierte arzneimittelzubereitung
SE462779B (sv) * 1988-10-10 1990-09-03 Lejus Medical Ab Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat
DE3909049A1 (de) * 1989-03-18 1990-09-20 Arthur Boskamp Praeparat und dessen verwendung
IT1231012B (it) * 1989-07-27 1991-11-08 Zambon Spa Composizione farmaceutica per uso orale contenente nac.
EP0497724B1 (fr) * 1991-01-26 1996-03-27 Senju Pharmaceutical Co., Ltd. Agent pour désintégrer des calculs biliares
DE4103360A1 (de) * 1991-02-05 1992-08-06 Koehler Peter Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
DE4406261C2 (de) * 1993-08-31 1996-07-04 Deutsches Krebsforsch Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
DE19509856C2 (de) * 1995-03-17 1997-09-11 Schwabe Willmar Gmbh & Co Verwendung einer Brausezusammensetzung mit Ginkgo-Biloba Trockenextrakt zur Behandlung peripherer und cerebraler Durchblutungsstörungen
WO2000018392A1 (fr) 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine-oxydase: antagonistes et inhibiteurs
AU772616B2 (en) 1998-09-25 2004-05-06 Protemix Corporation Limited Fructosamine oxidase assay: methods and materials
AU2003225442B2 (en) 2002-03-08 2010-02-04 Philera New Zealand Limited Preventing and/or treating cardiovascular disease and/or associated heart failure
WO2004017956A1 (fr) 2002-08-20 2004-03-04 Protemix Corporation Limited Formes posologiques et traitements s'y rapportant
AU2005281353A1 (en) 2004-07-19 2006-03-16 Philera New Zealand Limited Synthesis of triethylenetetramines
TR200900882A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
TR200900881A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
IT1399492B1 (it) * 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN102233139B (zh) * 2010-04-21 2012-09-05 重庆健能医药开发有限公司 一种乙酰半胱氨酸泡腾片及其制备方法和应用
EP2571499A1 (fr) * 2010-05-18 2013-03-27 Mahmut Bilgic Composition pharmaceutique contenant de la n- acétylcystéine et une xanthine
CN101947211A (zh) * 2010-08-28 2011-01-19 浙江金华康恩贝生物制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法
TR201104738A2 (tr) * 2011-05-16 2012-12-21 Bi̇lgi̇ç Mahmut N-Asetilsistein içeren farmasötik kombinasyon.
US8747894B2 (en) * 2012-05-08 2014-06-10 Alpex Pharma S.A. Effervescent compositions containing N-acetylcysteine
WO2015117987A1 (fr) 2014-02-05 2015-08-13 Sanovel Ilac Sanayi Ve Ticaret A.S. Formulations effervescentes comprenant de l'ibuprofène et de la n-acétylcystéine
CN113559078A (zh) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470M (fr) * 1962-03-13 1964-04-20 Mead Johnson & Co Composition thérapeutique.
ZA723683B (en) * 1971-07-12 1973-06-27 Hoffmann La Roche Improved effervescent preparations
DE3317558A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Orales antischnarchmittel
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
IT1170268B (it) * 1983-12-21 1987-06-03 Zambon Spa Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi
DE3514995A1 (de) * 1985-04-25 1986-10-30 Protopharma Ltd., 7831 Malterdingen Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut

Also Published As

Publication number Publication date
SE8702940L (sv) 1988-01-25
FR2601876A1 (fr) 1988-01-29
IT1222104B (it) 1990-08-31
DE3723735A1 (de) 1988-02-04
NL8701743A (nl) 1988-02-16
NL194067C (nl) 2001-06-05
BE1000355A3 (fr) 1988-11-08
GB2192790A (en) 1988-01-27
IT8721411A0 (it) 1987-07-23
NL194067B (nl) 2001-02-01
SE8702940D0 (sv) 1987-07-23
GB8717582D0 (en) 1987-09-03
CH667590A5 (it) 1988-10-31
SE500494C2 (sv) 1994-07-04
DE3723735C2 (fr) 1992-05-21
GB2192790B (en) 1990-01-31

Similar Documents

Publication Publication Date Title
FR2601876B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
FR2601875B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
PT81946A (fr) Procede de preparation de nouveaux derives de l'acide alpha-<oxo-2-hexahydro-2,4,5,6,7,7a-thieno(3,2-c)pyridyl-5>phenyl acetique et de compositions pharmaceutiques les contenant
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
FR2560523B1 (fr) Solution ophtalmique contenant du pranoprofene et de l'acide borique
MA20794A1 (fr) Perfectionnements apportes et se rattachant au procede d'obtention d'acide acetylsalicyclique
FR2581310B1 (fr) Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose
FR2585575B1 (fr) Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
PT78275B (fr) Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant
FR2490491B1 (fr) Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
FR2641189B1 (fr) Compositions pharmaceutiques contenant de l'acide acetyl salicylique et de la vitamine b6
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
FR2607005B1 (fr) Compositions pharmaceutiques contenant de l'acide ursodesoxycholique
FR2558828B1 (fr) " 1a,25-dihydroxy-22z-deshydrovitamine d " composition pharmaceutique et procede de preparation
FR2612774B1 (fr) Compositions cosmetiques et pharmaceutiques, utilisees pour traiter le processus de l'alopecie androgenogenetique, contenant de l'acide azelaique
FR2518537B1 (fr) Nouveaux derives de l'acide phenylacetique, leur preparation et compositions les contenant
FR2624731B1 (fr) Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique
FR2601950B1 (fr) N,n-dimethyl-n'-benzoyl-n' ((2,3-dihydro) benzofuran-2-yl-methyl) 1,3-propanediamine, preparation et compositions pharmaceutiques les contenant
FR2558468B1 (fr) Derives de l'acide b-(4-isocyano-1,2,3,4- diepoxycyclopentyl) acrylique et compositions, notamment pharmaceutiques, les contenant
FR2556592B1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
FR2555899B1 (fr) Composition pharmaceutique contenant au moins un derive d'acide glycyrrhetinique et au moins un derive de xanthine
FR2652086B1 (fr) Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name